Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
European Stocks Flat as Oil Prices Rise, US CPI in Focus 
Trump Unveils $3 Billion U.S. Critical Minerals Push 
US Yen Intervention Unlikely to Deliver Lasting Recovery, Yardeni Says 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Asian Currencies Steady as Markets Await U.S. Jobs Data 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Bets 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
US Dollar Gains as Iran Tensions, Fed Rate Hike Bets Rise 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.
